Alliancebernstein L.P. Cor Medix Inc. Transaction History
Alliancebernstein L.P.
- $290 Billion
- Q2 2025
A detailed history of Alliancebernstein L.P. transactions in Cor Medix Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 61,780 shares of CRMD stock, worth $699,967. This represents 0.0% of its overall portfolio holdings.
Number of Shares
61,780
Previous 49,780
24.11%
Holding current value
$699,967
Previous $306,000
148.69%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding CRMD
# of Institutions
187Shares Held
33.5MCall Options Held
867KPut Options Held
561K-
Vanguard Group Inc Valley Forge, PA4.33MShares$49 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.55MShares$40.3 Million0.0% of portfolio
-
Marshall Wace, LLP London, X02.58MShares$29.2 Million0.04% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il1.71MShares$19.4 Million0.0% of portfolio
-
State Street Corp Boston, MA1.6MShares$18.1 Million0.0% of portfolio
About CorMedix Inc.
- Ticker CRMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,208,200
- Market Cap $467M
- Description
- CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...